The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study

Journal of Thrombosis and Haemostasis

Volumn 14, Issue 12, 2016, Pages 2402-2409

  Kyrle, P A ^a,b   Kammer, M ^a   Eischer, L ^a   Weltermann, A ^c   Minar, E ^d   Hirschl, M ^e   Heinze, G ^a   Eichinger, S ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute of Thrombosis Research   (Austria)

^c ELISABETHINEN HOSPITAL   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

^e HANUSCH HOSPITAL   (Austria)

Author keywords

deep vein thrombosis; observational study; pulmonary embolism; relapse; venous thromboembolism

Indexed keywords

ADULT; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM; AGED; AUSTRIA; BLOOD; COMPLICATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; VEIN THROMBOSIS;

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANTS; AUSTRIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; SEX FACTORS; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85003888960     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13524     Document Type: Article

References (36)

1. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163–74.
2. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010; 376: 2032–9.
3. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12: 464–74.
4. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med 1995; 22: 1031–7.
5. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769–74.
6. Garcia-Fuster MJ, Forner MJ, Fernandez C, Gil J, Vaya A, Maldonado L. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb 2005; 34: 6–12.
7. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352–61.
8. Schulman S, Lindmarker P, Holmström M, Lafars G, Carlsson A, Nicol P, Svensson E, Lungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4: 734–42.
9. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simion P, Pagnan A. The risk of recurrent VTE after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199–205.
10. Mello TB, Orsi FL, Montalvao SA, Ozel MC, de Paula EV, Annichinno-Bizzachi JM. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population. Blood Coagul Fibrinolysis 2010; 2: 660–5.
11. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U. Mortality and recurrence after treatment of venous thromboembolism: long term follow-up of patients with good life-expectancy. Thromb Res 2011; 127: 540–6.
12. Sveinsdottir SV, Saemundsson Y, Isma N, Gottsäter A, Svensson PJ. Evaluation of recurrent venous thromboembolism in patients with factor V Leiden mutation in heterozygous form. Thromb Res 2012; 130: 467–71.
13. Rodger MA, Scarvelis D, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Gandara E, Solymoss S, Sabri E, Kovacs M. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: a multi-national cohort. Thromb Res 2016; 143: 152–8.
14. Kyrle PA, Eischer L. Predicting the risk of recurrent venous thromboembolism. The Austrian Study on Recurrent VTE (AUREC). Haemostaseologie 2013; 33: 201–9.
15. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Circulation 2010; 121: 1630–6.
16. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753–69.
17. Wolbers M, Koller MT, Stel VS, Schaer B, Jager KJ, Leffondré K, Heinze G. Competing risks analyses: objectives and approaches. Eur Heart J 2014; 35: 2936–41.
18. Eischer L, Eichinger S, Kyrle PA. The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study. J Thromb Haemost 2014; 12: 635–40.
19. Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 2016a; 14: 1480–3.
20. Koller MT, Raatz H, Steyerberg EW, Wolbers M. Competing risks and the clinical community: irrelevance or ignorance? Stat Med 2012; 31: 1089–97.
21. Baglin T, Douketis J, Tosetto A, Marcucci M, Cushman M, Kyrle P, Palareti G, Poli D, Tait RC, Iorio A. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis J Thromb Haemost 2010; 8: 2436–42.
22. Eichinger S, Weltermann A, Minar E, Stain M, Schönauer V, Schneider B, Kyrle PA. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92–6.
23. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558–63.
24. McRae S, Tran H, Schulman S, Ginsberg J, Kearon C. Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 2006; 368: 371–8.
25. Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 24:342: d813.
26. Roach RE, Lijfering WM, Tait RC, Baglin T, Kyrle PA, Cannegieter SC, Rosendaal FR. Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts. J Thromb Haemost 2015; 13: 1815–22.
27. Eischer L, Eichinger S, Kyrle PA. Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore) 2009; 88: 366–70.
28. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016b; 149: 315–52.
29. Kuijer PM, Hutten BA, Prins MH, Büller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 1999; 159: 457–60.
30. Ruíz-Giménez N, Suárez C, González R, Nieto JA, Todolí JA, Samperiz AL, Monreal M; RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26–31.
31. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91–9.
32. Donzé J, Rodondi N, Waeber G, Monney P, Cornuz J, Aujesky D. Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study. Am J Med 2012; 125: 1095–102.
33. Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 2013; 35: 312–9.
34. Scherz N, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Husmann M, Egloff M, Aschwanden M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism. J Thromb Haemost 2013; 11: 435–43.
35. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 2014; 130: 1062–71.
36. Kyrle PA. How I treat recurrent deep-vein thrombosis. Blood 2016; 127: 696–702.